SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-127208
Filing Date
2024-12-10
Accepted
2024-12-10 16:30:37
Documents
14
Period of Report
2024-12-05
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430603d1_8k.htm   iXBRL 8-K 73068
2 EXHIBIT 3.1 tm2430603d1_ex3-1.htm EX-3.1 7385
  Complete submission text file 0001104659-24-127208.txt   260734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20241205.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20241205_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20241205_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2430603d1_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 241538928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)